Rosiglitazone to Reverse Metabolic Defects in Diabetes

NCT00094796 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
70
Enrollment
NIH
Sponsor class

Conditions

Interventions

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)